Atossa Therapeutics
ATOS
#10641
Rank
โ‚น2.50 B
Marketcap
โ‚น250.91
Share price
-0.38%
Change (1 day)
276.84%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -โ‚น3.38 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น3.32 Billion a decrease over its 2024 earnings that were of -โ‚น2.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น3.38 Billion1.67%
2025 -โ‚น3.32 Billion36.33%
2024 -โ‚น2.44 Billion-15.25%
2023 -โ‚น2.88 Billion11.62%
2022 -โ‚น2.58 Billion30.84%
2021 -โ‚น1.97 Billion15.58%
2020 -โ‚น1.71 Billion3.41%
2019 -โ‚น1.65 Billion51.16%
2018 -โ‚น1.09 Billion40.41%
2017 -โ‚น0.78 Billion27.54%
2016 -โ‚น0.61 Billion-47.49%
2015 -โ‚น1.16 Billion-17.25%
2014 -โ‚น1.4 Billion35.91%
2013 -โ‚น1.03 Billion112.3%
2012 -โ‚น0.49 Billion46.53%
2011 -โ‚น0.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.478 T-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น131.27 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น131.19 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.97 B-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น9.49 Billion 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น0.75 Billion-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA